Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP643099.RAw-GBXuIHoQx0HJ_hngp919AVblQPOYzNPKJqCrZLysI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP643099.RAw-GBXuIHoQx0HJ_hngp919AVblQPOYzNPKJqCrZLysI130_assertion type Assertion NP643099.RAw-GBXuIHoQx0HJ_hngp919AVblQPOYzNPKJqCrZLysI130_head.
- NP643099.RAw-GBXuIHoQx0HJ_hngp919AVblQPOYzNPKJqCrZLysI130_assertion description "[Pak1 in the cytoplasm was an independent prognostic marker, indicating increased recurrence rate (HR, 1.79; 95% CI, 1.17-2.74; P = 0.0068) and breast cancer mortality (HR, 1.98; 95% CI, 1.14-3.46; P = 0.016) for patients randomized to no adjuvant treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP643099.RAw-GBXuIHoQx0HJ_hngp919AVblQPOYzNPKJqCrZLysI130_provenance.
- NP643099.RAw-GBXuIHoQx0HJ_hngp919AVblQPOYzNPKJqCrZLysI130_assertion evidence source_evidence_literature NP643099.RAw-GBXuIHoQx0HJ_hngp919AVblQPOYzNPKJqCrZLysI130_provenance.
- NP643099.RAw-GBXuIHoQx0HJ_hngp919AVblQPOYzNPKJqCrZLysI130_assertion SIO_000772 20179234 NP643099.RAw-GBXuIHoQx0HJ_hngp919AVblQPOYzNPKJqCrZLysI130_provenance.
- NP643099.RAw-GBXuIHoQx0HJ_hngp919AVblQPOYzNPKJqCrZLysI130_assertion wasDerivedFrom befree-20150227 NP643099.RAw-GBXuIHoQx0HJ_hngp919AVblQPOYzNPKJqCrZLysI130_provenance.
- NP643099.RAw-GBXuIHoQx0HJ_hngp919AVblQPOYzNPKJqCrZLysI130_assertion wasGeneratedBy ECO_0000203 NP643099.RAw-GBXuIHoQx0HJ_hngp919AVblQPOYzNPKJqCrZLysI130_provenance.